Department of Surgical Oncology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Cancer Sci. 2010 Sep;101(9):2074-9. doi: 10.1111/j.1349-7006.2010.01630.x.
The roles of core needle biopsy (CNB) have become well established as an important preoperative diagnostic method for breast lesions. We examined the concordance of histological types, nuclear grades, hormone receptors, and human epidermal growth factor receptor 2 (HER2) status between CNB and surgical specimens in 353 cases. In addition, we analyzed the correlation between the number of CNB specimens obtained and accuracy of histological factors in order to explore the optimal number of CNB specimens. Between CNB and surgical specimens, concordance rates of histological type, nuclear grade, estrogen receptor (ER), and progesterone receptor (PgR) status (cut-off 0-<1%, 1-10%, and 10%<), and HER2 were 84.4%, 81.3%, 92.9%, and 89.3%, respectively. In 52 of 353 patients who were histopathologically diagnosed as ductal carcinoma in situ (DCIS) by CNB, final diagnosis was changed in to invasive ductal carcinoma (IDC) in surgical specimens. Statistically significant differences were detected in the discrepancy of the following factors between CNB and subsequent surgical specimens: histological types, nuclear grade, and PgR, between patients who received four or more cores and those who had received three or less cores. In addition, a similar tendency was also detected in estrogen receptor (ER) and HER2 as in the above, and the cases that received four cores reached to 100% concordance in diagnosis between CNB and surgical specimens. Therefore, the optimal numbers of CNB were considered four at least in assessing the histological type, invasion, nuclear grade, hormone receptor status, and HER2 status of individual patients in the preoperative setting.
核心针活检 (CNB) 在乳腺病变的术前诊断中已成为一种重要的方法,其作用已经得到了充分的证实。我们检查了 353 例患者的 CNB 与手术标本的组织学类型、核分级、激素受体和人表皮生长因子受体 2(HER2)状态的一致性。此外,我们还分析了获得的 CNB 标本数量与组织学因素准确性之间的相关性,以探讨获得最佳 CNB 标本数量的方法。在 CNB 与手术标本之间,组织学类型、核分级、雌激素受体(ER)和孕激素受体(PgR)状态(截断值 0-<1%、1-10%和 10%<)以及 HER2 的一致性率分别为 84.4%、81.3%、92.9%和 89.3%。在 353 例经 CNB 病理诊断为导管原位癌(DCIS)的患者中,52 例最终诊断在手术标本中更改为浸润性导管癌(IDC)。在 CNB 与后续手术标本之间,组织学类型、核分级和 PgR 的差异在接受 4 个或更多核心与接受 3 个或更少核心的患者之间存在统计学显著差异。此外,在 ER 和 HER2 方面也存在类似的趋势,接受 4 个核心的病例在 CNB 和手术标本之间的诊断一致性达到 100%。因此,在术前评估患者的组织学类型、浸润程度、核分级、激素受体状态和 HER2 状态时,至少需要进行 4 次 CNB。